Jung Hwa Jin, Suh Yousin
Department of Genetics, Albert Einstein College of Medicine New York, NY, USA.
Department of Genetics, Albert Einstein College of Medicine New York, NY, USA ; Department of Medicine, Albert Einstein College of Medicine New York, NY, USA ; Institute for Aging Research, Diabetes Research and Training Center, Albert Einstein College of Medicine New York, NY, USA.
Front Genet. 2015 Jan 13;5:472. doi: 10.3389/fgene.2014.00472. eCollection 2014.
The insulin-like growth factor 1 (IGF-1) signaling pathway regulates critical biological processes including development, homeostasis, and aging. Dysregulation of this pathway has been implicated in a myriad of diseases such as cancers, neurodegenerative diseases, and metabolic disorders, making the IGF-1 signaling pathway a prime target to develop therapeutic and intervention strategies. Recently, small non-coding RNA molecules in ∼22 nucleotide length, microRNAs (miRNAs), have emerged as a new regulator of biological processes in virtually all organ systems and increasing studies are linking altered miRNA function to disease mechanisms. A miRNA binds to 3'UTRs of multiple target genes and coordinately downregulates their expression, thereby exerting a profound influence on gene regulatory networks. Here we review the components of the IGF-1 signaling pathway that are known targets of miRNA regulation, and highlight recent studies that suggest therapeutic potential of these miRNAs against various diseases.
胰岛素样生长因子1(IGF-1)信号通路调节包括发育、体内平衡和衰老在内的关键生物学过程。该通路的失调与多种疾病有关,如癌症、神经退行性疾病和代谢紊乱,这使得IGF-1信号通路成为开发治疗和干预策略的主要靶点。最近,长度约为22个核苷酸的小非编码RNA分子,即微小RNA(miRNA),已成为几乎所有器官系统中生物过程的新调节因子,并且越来越多的研究将miRNA功能改变与疾病机制联系起来。miRNA与多个靶基因的3'非翻译区(3'UTR)结合并协同下调其表达,从而对基因调控网络产生深远影响。在这里,我们综述了已知受miRNA调控的IGF-1信号通路的组成部分,并强调了最近的研究,这些研究表明这些miRNA对各种疾病具有治疗潜力。